or
forgot password

    • cancer clinical trials in las vegas, NV

    • 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
    Boehringer Ingelheim Investigational Site
    Las Vegas, Nevada
    HIV Infections
    Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Non-Small Cell Lung Cancer and Pleural Mesothelioma
    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
    University Medical Center of Southern Nevada

    Trial Locations
    University Medical Center of Southern Nevada
    Nevada Cancer Research Foundation CCOP
    Recurrent Melanoma, Stage IV Melanoma
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Comprehensive Cancer Centers of Nevada
    Las Vegas, Nevada 89109
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
    Comprehensive Cancer Centers of Nevada
    Las Vegas, Nevada 89109
    Carcinoma, Non-Small-Cell Lung
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Comprehensive Cancer Centers of Nevada
    Las Vegas, Nevada 89109
    Metastatic Breast Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    University Medical Center of Southern Nevada

    Trial Locations
    University Medical Center of Southern Nevada
    Nevada Cancer Research Foundation CCOP
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Sunrise Hospital and Medical Center
    Las Vegas, Nevada 89109-2306
    Neuroblastoma
    Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
    CCOP - Nevada Cancer Research Foundation

    Trial Locations
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Colorectal Cancer
    A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Thrombosis, Cancer, Pulmonary Embolism
    A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Las Vegas, Nevada 89169
    Non-Small Cell Lung Cancer
    Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Non-Hodgkin's Lymphoma
    Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer
    Nevada Cancer Research Foundation
    Las Vegas, Nevada 89109
    Non-small Cell Lung Cancer
    Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
    Comprehensive Cancer Centers of Nevada
    Las Vegas, Nevada 89109
    Small Cell Lung Cancer
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Nevada Cancer Research Foundation CCOP
    Las Vegas, Nevada 89106
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Vidaza to Restore Hormone Thx Prostate
    Comprehensive Cancer Centers of Nevada
    Las Vegas, Nevada 89109
    Prostate Cancer
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    Nevada Cancer Institute

    Trial Locations
    Nevada Cancer Institute
    Nevada Cancer Centers
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    A Safety and Efficacy Study in Patients With Gastric Cancer
    Southern Nevada Cancer Research Foundation
    Las Vegas, Nevada 89106
    Gastric Cancer
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    CCOP - Nevada Cancer Research Foundation

    Trial Locations
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment
    Assessing Older Patients With Cancer
    University Medical Center of Southern Nevada
    Las Vegas, Nevada 89102
    Unspecified Adult Solid Tumor, Protocol Specific
    Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Ovarian, Melanoma, Renal, Prostate, Colorectal, Endometrial Carcinoma, Cervical Carcinoma, Testicular Cancer, Thyroid Cancer, Small Cell Lung Carcinoma, Mesothelioma, Breast Carcinoma, Esophageal Carcinoma, Gastric Cancer, Pancreatic Carcinoma, Neuroendocrine Cancer, Liver Cancer, Gallbladder Cancer, Biliary Tract Cancer, Anal Carcinoma, Bone Sarcomas, Soft Tissue Sarcomas, Carcinoma of Unknown Origin, Primary
    Phase 2 Trial of Enzastaurin in Prostate Cancer in Patients Who Have Had Hormonal and Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Las Vegas, Nevada 89169
    Prostate Cancer
    Study of EC0225 for the Treatment of Refractory or Metastatic Tumors
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Cancer
    A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
    Pfizer Investigational Site
    Las Vegas, Nevada 89128
    Neoplasms
    Assessment and Tracking of Long-term Alefacept Safety


    Trial Locations

    Johnnie M Woodson
    Robert B. Stromling, MD
    Psoriasis
    A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone
    Pfizer Investigational Site
    Las Vegas, Nevada 89128
    Carcinoma, Non-Small Cell Lung
    Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Las Vegas, Nevada 89128
    Colorectal Neoplasms
    A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Bladder Cancer, Breast Cancer, Colorectal Cancer, Gastrointestinal Neoplasm, Head and Neck Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer
    A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Las Vegas, Nevada 89169
    Prostate Cancer
    Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
    Site Facility
    Las Vegas, Nevada 89146
    Hypoactive Sexual Desire Disorder
    Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
    Sunrise Hospital and Medical Center
    Las Vegas, Nevada 89109-2306
    Sarcoma
    Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
    Pfizer Investigational Site
    Las Vegas, Nevada 89128
    Carcinoma, Pancreatic Ductal
    A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors, Neoplasms, Colorectal
    A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Las Vegas, Nevada 89169
    Non-Small-Cell Lung Cancer
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    CCOP - Nevada Cancer Research Foundation
    Las Vegas, Nevada 89109-2306
    Leukemia
    Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Hormone Refractory Prostate Cancer
    An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Las Vegas, Nevada 89169
    Lung Neoplasms